-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Denali Therapeutics Inc. (DNLI)
-
-
-
-
-
-
-
Denali Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
-
-
-
-
-
-
-
Denali Therapeutics Announces Proposed Offering of Common Stock
-
-
-
-
-
-
-
Denali Therapeutics Reports Full Year 2020 Financial Results and Business Highlights
-
-
-
-
-
-
-
H.C. Wainwright Starts Denali Therapeutics Inc. (DNLI) at Buy
21,798 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

